Defining the clinical response to 17-alpha hydroxyprogesterone caproate

Am J Obstet Gynecol. 2018 Dec;219(6):623-625. doi: 10.1016/j.ajog.2018.08.040. Epub 2018 Aug 29.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • 17 alpha-Hydroxyprogesterone Caproate / administration & dosage
  • 17 alpha-Hydroxyprogesterone Caproate / therapeutic use*
  • Female
  • Gestational Age
  • Humans
  • Pregnancy
  • Pregnancy Outcome
  • Premature Birth / prevention & control*
  • Progestins / administration & dosage
  • Progestins / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Time Factors

Substances

  • Progestins
  • 17 alpha-Hydroxyprogesterone Caproate